$1.63
0.074.49%
In chiusura: -
$1.61
-0.02-1.23%
After hour: Oct 24, 6:05 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Ovid Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-0.150
Stima dei ricavi trimestrali
$238.23K
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$6.65M
Analizza lo storico degli utili di Ovid Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics | -$0.20 | -$0.15 | — | — | $173.00K | $238.23K | — | — | 11/11/2025 | |
OVID | Ovid Therapeutics | $0.12 | -$0.15 | -$0.06 | 60.00% | $169.00K | $115.08K | $6.27M | 5350.12% | 08/13/2025 | |
OVID | Ovid Therapeutics | -$0.17 | -$0.13 | -$0.14 | -7.69% | $148.00K | $33.33K | $130.00K | 290.04% | 05/13/2025 | |
OVID | Ovid Therapeutics | -$0.22 | -$0.17 | -$0.13 | 23.53% | $141.56K | $187.50K | $76.00K | -59.47% | 03/11/2025 | |
OVID | Ovid Therapeutics | -$0.16 | -$0.19 | -$0.20 | -5.26% | $108.97K | $87.14K | $173.00K | 98.52% | 11/12/2024 | |
OVID | Ovid Therapeutics | -$0.18 | -$0.22 | $0.12 | 154.55% | $75.00K | $70.00K | $169.00K | 141.43% | 08/13/2024 | |
OVID | Ovid Therapeutics | -$0.19 | -$0.22 | -$0.17 | 22.73% | $66.00K | $60.00K | $148.00K | 146.67% | 05/14/2024 | |
OVID | Ovid Therapeutics | -$0.16 | -$0.05 | -$0.22 | -340.00% | $46.28K | $60.00K | $141.56K | 135.94% | 03/08/2024 | |
OVID | Ovid Therapeutics | -$0.17 | -$0.19 | -$0.16 | 15.79% | $11.10K | $50.00K | $108.97K | 117.94% | 11/03/2023 | |
OVID | Ovid Therapeutics | -$0.21 | -$0.20 | -$0.18 | 10.00% | $0.00 | $50.00K | $75.00K | 50.00% | 08/04/2023 | |
OVID | Ovid Therapeutics | -$0.23 | -$0.17 | -$0.19 | -11.76% | $1.45M | $20.00K | $66.16K | 230.80% | 05/05/2023 | |
OVID | Ovid Therapeutics | -$0.38 | -$0.18 | -$0.16 | 11.11% | $0.00 | — | $46.28K | — | 03/13/2023 | |
OVID | Ovid Therapeutics | -$0.17 | -$0.21 | -$0.17 | 19.05% | $0.00 | — | $11.10K | — | 11/08/2022 | |
OVID | Ovid Therapeutics | -$0.23 | -$0.25 | -$0.21 | 16.00% | $0.00 | — | $0.00 | — | 08/09/2022 | |
OVID | Ovid Therapeutics | $2.53 | -$0.21 | -$0.23 | -9.52% | $208.38M | — | $1.45M | — | 05/10/2022 | |
OVID | Ovid Therapeutics | -$0.34 | -$0.16 | -$0.38 | -137.50% | $5.70M | — | $0.00 | — | 03/15/2022 | |
OVID | Ovid Therapeutics | -$0.28 | — | -$0.17 | — | $6.91M | — | $0.00 | — | 11/10/2021 | |
OVID | Ovid Therapeutics | -$0.41 | -$0.16 | -$0.23 | -43.75% | $0.00 | — | $0.00 | — | 08/16/2021 | |
OVID | Ovid Therapeutics | -$0.37 | -$0.14 | $2.53 | 1907.14% | $0.00 | $1.29M | $208.38M | 16053.72% | 05/13/2021 | |
OVID | Ovid Therapeutics | -$0.35 | — | -$0.34 | — | $0.00 | — | $5.70M | — | 03/15/2021 | |
OVID | Ovid Therapeutics | -$0.43 | -$0.36 | -$0.28 | 22.22% | $0.00 | $80.00K | $6.91M | 8542.50% | 11/12/2020 |
Ovid Therapeutics (OVID) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-13 | $-0.06 | $-0.15 | 60.0 % |
| Q1 | 2025-05-13 | $-0.14 | $-0.13 | -7.69 % |
| Q4 | 2025-03-11 | $-0.13 | $-0.17 | 23.5 % |
| Q3 | 2024-11-12 | $-0.20 | $-0.19 | -5.26 % |
Ovid Therapeutics (OVID) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-13 | $6.27M | $115.08K | 5350.1 % |
| Q1 | 2025-05-13 | $130.00K | $33.33K | 290.0 % |
| Q4 | 2025-03-11 | $76.00K | $187.50K | -59.5 % |
| Q3 | 2024-11-12 | $173.00K | $87.14K | 98.5 % |
FAQ
Quando Ovid Therapeutics (NASDAQ:OVID) riporterà gli utili?
Si prevede che Ovid Therapeutics (OVID) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 13, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Ovid Therapeutics (NASDAQ:OVID)?
L'EPS effettivo era $-0.06, che superato la stima di $-0.15.
Quali sono state le entrate di Ovid Therapeutics (NASDAQ:OVID)?
Le entrate effettive sono state $6.3M, che superato la stima di $115.1K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.